European Urology Oncology

Slides:

Advertisements

Similar presentations

Fig.1 Complexity of the surgeries according to BAS. Histogram.

Advertisements

Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy,

Volume 62, Issue 3, Pages (September 2012)

European Urology Oncology

Volume 49, Issue 2, Pages (February 2006)

Association between Smoking, Passive Smoking, and Erectile Dysfunction: Results from the Boston Area Community Health (BACH) Survey Varant Kupelian,

Volume 67, Issue 3, Pages (March 2015)

Volume 68, Issue 3, Pages (September 2015)

Volume 69, Issue 1, Pages (January 2016)

European Urology Oncology

Volume 73, Issue 1, Pages (January 2018)

Volume 63, Issue 3, Pages e39-e40 (March 2013)

Volume 71, Issue 4, Pages (April 2017)

European Urology Oncology

Volume 193, Issue 4, Pages e688-e689 (April 2015)

Risk-Adjusted Prolonged Length of Stay as an Alternative Outcome Measure for Pediatric Congenital Cardiac Surgery Ming Liu, MS, MA, Charlotte M. Druschel,

Adjuvant Antiangiogenic Agents in Post-nephrectomy Renal Cell Carcinoma: A Systematic Review and Meta-analysis Mohamad B. Sonbol, Belal Firwana, Talal.

Volume 67, Issue 3, Pages (March 2015)

Volume 73, Issue 3, Pages (March 2018)

European Urology Oncology

Volume 61, Issue 4, Pages (April 2012)

European Urology Oncology

Volume 71, Issue 6, Pages (June 2017)

European Urology Oncology

Volume 72, Issue 5, Pages (November 2017)

Volume 65, Issue 2, Pages (February 2014)

Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases Axel Heidenreich, Nicola Fossati, David Pfister, Nazareno Suardi,

Volume 66, Issue 6, Pages (December 2014)

Rectal Injury During Radical Prostatectomy: Focus on Robotic Surgery

Performance Prediction for Surgical Outcomes in Partial Nephrectomy Using Nephrometry Scores: A Comparison of Arterial Based Complexity (ABC), RENAL,

Volume 63, Issue 3, Pages (March 2013)

Volume 60, Issue 6, Pages (December 2011)

National Norwegian Practice Patterns for Surgical Treatment of Kidney Cancer Tumors ≤7cm: Adherence to Changes in Guidelines May Improve Overall Survival

Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G

Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study Oskar Bergengren, Hans Garmo, Ola Bratt, Lars Holmberg,

European Urology Oncology

European Urology Oncology

Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA Nawar Hanna, Quoc-Dien Trinh,

Comparison of risk factors for length of stay and readmission following lower extremity bypass surgery Scott M. Damrauer, MD, Ann C. Gaffey, MD, Ann.

European Urology Oncology

European Urology Oncology

Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy Matthew Mossanen, Kenneth.

Volume 74, Issue 4, Pages (October 2018)

European Urology Oncology

Is Robot-assisted Surgery Contraindicated in the Case of Partial Nephrectomy for Complex Tumours or Relevant Comorbidities? A Comparative Analysis of.

Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer Felix Preisser, Michele Marchioni, Sebastiano.

Functional and Oncologic Outcomes Between Open and Robotic Radical Prostatectomy at 24-month Follow-up in the Swedish LAPPRO Trial Martin Nyberg, Jonas.

European Urology Oncology

Volume 71, Issue 3, Pages (March 2017)

Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature Liliana Vartolomei, Shahrokh F. Shariat, Mihai.

Correlations between Apparent Diffusion Coefficient and Gleason Score in Prostate Cancer: A Systematic Review Alexey Surov, Hans Jonas Meyer, Andreas.

European Urology Oncology

Preventing Osteoporosis in Men Taking Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis Joseph Sargon Joseph, Vincent.

The Cost to Medicare of Bladder Cancer Care

Axel Heidenreich European Urology Supplements

The Role of Systematic and Targeted Biopsies in Light of Overlap on Magnetic Resonance Imaging Ultrasound Fusion Biopsy Neal Patel, Eliza Cricco-Lizza,

European Urology Oncology

European Urology Oncology

European Urology Oncology

European Urology Oncology

Axel Heidenreich European Urology Supplements

Volume 51, Issue 5, Pages (May 2007)

European Urology Oncology

Salvage Local Treatments After Focal Therapy for Prostate Cancer

European Urology Oncology

European Urology Oncology

European Urology Oncology

Maximilian Burger, Ashish M. Kamat, David McConkey

How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder? Shahrokh Shariat, Paolo Gontero, James.

European Urology Oncology

Presentation transcript:

European Urology Oncology Frailty and Greater Health Care Resource Utilization Following Major Urologic Oncology Surgery Benjamin L. Taylor, Leilei Xia, Thomas J. Guzzo, Douglas S. Scherr, Jim C. Hu European Urology Oncology DOI: 10.1016/j.euo.2018.06.005 Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 1 (A) Subjects with greater health care resource utilization (HRU), prolonged length of stay (PLOS), discharge to continued care (DCC), and unplanned readmission (UR) stratified by five-item frailty index (FFI). (B) Subjects with greater HRU stratified by surgery and FFI. MIRP=minimally invasive radical prostatectomy; RRP=radical retropubic prostatectomy; MIRN=minimally invasive radical nephrectomy; ORN=open radical nephrectomy; MIPN=minimally invasive partial nephrectomy; OPN=open partial nephrectomy; RC=radical cystectomy. European Urology Oncology DOI: (10.1016/j.euo.2018.06.005) Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 2 Multivariable logistic regression model of the associations between the five-item frailty index (FFI) and greater health care resource utilization (HRU) across all urologic oncology surgery. OR=odds ratio; CI=confidence interval. European Urology Oncology DOI: (10.1016/j.euo.2018.06.005) Copyright © 2018 European Association of Urology Terms and Conditions

European Urology Oncology DOI: (10.1016/j.euo.2018.06.005) Copyright © 2018 European Association of Urology Terms and Conditions

European Urology Oncology DOI: (10.1016/j.euo.2018.06.005) Copyright © 2018 European Association of Urology Terms and Conditions